OKUR vs STZ · P/E 72, rev $2.0M vs P/E 14, rev $9.14B
OnKure Therapeutics, Inc. (OKUR) versus Constellation Brands Inc Class A (STZ) — a side-by-side from cached financials, not a winner call.
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
Constellation Brands Inc Class A (STZ) is a beverages - brewers company listed on US.
Latest reported OKUR revenue for 2026-06-30 was $2.0M. Net income was -$30.5M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
Latest reported STZ revenue for 2026-02-28 was $9.14B. Net income was $1.69B. Revenue was up 322.3% from 2025-02-28 to 2026-02-28. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
OKUR currently screens at market cap $76.6M and trailing P/E 71.8. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
Not investment advice. Open the OKUR and STZ stock pages for the full models.
Not investment advice.